Stem cell factor and hematopoiesis

Blood

Volumn 90, Issue 4, 1997, Pages 1345-1364

  Broudy, Virginia C ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 11; INTERLEUKIN 3; INTERLEUKIN 6; PROTEIN TYROSINE KINASE; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR;

B LYMPHOCYTE; BONE MARROW CELL; BURST FORMING UNIT E; CELL ADHESION; COLONY FORMING UNIT GEMM; COLONY FORMING UNIT S; GERM CELL; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; MACROCYTIC ANEMIA; MAST CELL; MELANOCYTE; NONHUMAN; PANCYTOPENIA; POINT MUTATION; PRENATAL GROWTH; PRIORITY JOURNAL; PROTEIN STRUCTURE; RADIATION; REVIEW;

EID: 0030846533     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.4.1345     Document Type: Review

References (313)

1. Metcalf D: Hematopoietic regulators: Redundancy or subtlety? Blood 82:3515, 1993
2. Williams DE, Eisenman J, Baird A, Rauch C, Ness KV, March CJ, Park LS, Martin U, Mochizuki DY, Boswell HS, Burgess GS, Cosman D, Lyman SD: Identification of a ligand for the c-kit proto-oncogene. Cell 63:167, 1990
3. Flanagan JG, Leder P: The kit ligand: A cell surface molecule altered in steel mutant fibroblasts. Cell 63:185, 1990
4. Zsebo KM, Williams DA, Geissler EN, Broudy VC, Martin FH, Atkins HL, Hsu R-Y, Birkett NC, Okino KH, Murdock DC, Jacobsen FW, Langley KE, Smith KA, Takeishi T, Cattanach BM, Galli SJ, Suggs SV: Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 63:213, 1990
5. Huang E, Nocka K, Beier DR, Chu T-Y, Buck J, Lahm H-W, Wellner D, Leder P, Besmer P: The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus. Cell 63:225, 1990
6. Russell ES: Hereditary anemias of the mouse: A review for geneticists. Adv Genet 20:357, 1979
7. Geissler EN, McFarland EC, Russell ES: Analysis of pleiotropism at the dominant white-spotting (W) locus of the house mouse: A description of ten new W alleles. Genetics 97:337, 1981
8. Besmer P, Manova K, Duttlinger R, Huang EJ, Packer A, Gyssler C, Bachvarova RF: The kit-ligand (steel factor) and its receptor c-kit/W: Pleiotropic roles in gametogenesis and melanogenesis. Development 125, 1993 (suppl)
9. 42 spotting phenotype results from a missense mutation in the c-kit receptor kinase. Science 247:209, 1990
10. Blouin R, Bernstein A: The white spotting and steel hereditary anemias of the mouse, in Feig SA, Freedman MH (eds): Clinical Disorders and Experimental Models of Erythropoietic Failure. Boca Raton, FL, CRC, 1993, p 157
11. Huizinga JD, Thuneberg L, Klüppel M, Malysz J, Mikkelsen HB, Bernstein A: W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity. Nature 373:347, 1995
12. Maeda H, Yamagata A, Nishikawa S, Yoshinaga K, Kobayashi S, Nishi K, Nishikawa S-I: Requirement of c-kit for development of intestinal pacemaker system. Development 116:369, 1992
13. Reith AD, Rottapel R, Giddens E, Brady C, Forrester L, Bernstein A: W mutant mice with mild or severe developmental defects contain distinct point mutations in the kinase domain of the c-kit receptor. Genes Dev 4:390, 1990
14. d mutant. Cell 64:1025, 1991
15. Brannan CI, Lyman SD, Williams DE, Eisenman J, Anderson DM, Cosman D, Bedell MA, Jenkins NA, Copeland NG: Steel-dickie mutation encodes a c-Kit ligand lacking transmembrane and cytoplasmic domains. Proc Natl Acad Sci USA 88:4671, 1991
16. Orr-Urtreger A, Avivi A, Zimmer Y, Givol D, Yarden Y, Lonai P: Developmental expression of c-kit, a proto-oncogene encoded by the W locus. Development 109:911, 1990
17. Matsui Y, Zsebo KM, Hogan BLM: Embryonic expression of a haematopoietic growth factor encoded by the Sl locus and the ligand for c-kit. Nature 347:667, 1990
18. Keshet E, Lyman SD, Williams DE, Anderson DM, Jenkins NA, Copeland NG, Parada LF: Embryonic RNA expression patterns of the c-kit receptor and its cognate ligand suggest multiple functional roles in mouse development. EMBO J 10:2425, 1991
19. Palacios R, Nishikawa S-I: Developmentally regulated cell surface expression and function of c-kit receptor during lymphocyte ontogeny in the embryo and adult mice. Development 115:1133, 1992
20. Motro B, Wojtowicz JM, Bernstein A, van der Kooy D: Steel mutant mice are deficient in hippocampal learning but not long-term potentiation. Proc Natl Acad Sci USA 93:1808, 1996
21. Ogawa M, Matsuzaki Y, Nishikawa S, Hayashi S-I, Kunisada T, Sudo T, Kina T, Nakauchi H, Nishikawa S-I: Expression and function of c-kit in hemopoietic progenitor cells. J Exp Med 174:63, 1991
22. Heinrich MC, Dooley DC, Freed AC, Band L, Hoatlin ME, Keeble WW, Peters ST, Silvey KV, Ey FS, Kabat D, Maziarz RT, Bagby GC Jr: Constitutive expression of steel factor gene by human stromal cells. Blood 82:771, 1993
23. Linenberger ML, Jacobsen FW, Bennett LG, Broudy VC, Martin FH, Abkowitz JL: Stem cell factor production by human marrow stromal fibroblasts. Exp Hematol 23:1104, 1995
24. Broudy VC, Lin NL, Priestley GV, Nocka K, Wolf NS: Interaction of stem cell factor and its receptor c-kit mediates lodgment and acute expansion of hematopoietic cells in the murine spleen. Blood 88:75, 1996
25. Yoshinaga K, Nishikawa S, Ogawa M, Hayashi S-I, Kunisada T, Fujimoto T, Nishikawa S-I: Role of c-kit in mouse spermatogenesis: Identification of spermatogonia as a specific site of c-kit expression and function. Development 113:689, 1991
26. Nishikawa S, Kusakabe M, Yoshinaga K, Ogawa M, Hayashi S, Kunisada T, Era T, Sakakura T, Nishikawa S: In utero manipulation of coat color formation by a monoclonal anti-c-kit antibody: Two distinct waves of c-kit-dependency during melanocyte development. EMBO J 10:2111, 1991
27. Donaldson LE, Schmitt E, Huntley JF, Newlands GFJ, Grencis RK: A critical role tor stem cell factor and c-kit in host protective immunity to an intestinal helminth. Int Immunol 8:559, 1996
28. Copeland NG, Gilben DJ, Cho BC, Donovan PJ, Jenkins NA, Cosman D, Anderson D, Lyman SD, Williams DE: Mast cell growth factor maps near the steel locus on mouse chromosome 10 and is deleted in a number of steel alleles. Cell 63:175, 1990
29. Anderson DM, Williams DE, Tushinski R, Gimpel S, Eisenman J, Cannizzaro LA, Aronson M, Croce CM, Huebner K, Cosman D, Lyman SD: Alternate splicing of mRNAs encoding human mast cell growth factor and localization of the gene to chromosome 12q22-q24. Cell Growth Differ 2:373, 1991
30. Geissler EN, Liao M, Brook JD, Martin FH, Zsebo KM, Housman DE, Galli SJ: Stem cell factor (SCF), a novel hematopoietic growth factor and ligand for c-kit tyrosine kinase receptor, maps on human chromosome 12 between 12q14.3 and 12qter. Somatic Cell Mol Genet 17:207, 1991
31. Galli SJ, Zsebo KM, Geissler EN: The kit ligand, stem cell factor. Adv Immunol 55:1, 1994
32. Huang EJ, Nocka KH, Buck J, Besmer P: Differential expression and processing of two cell associated forms of the kit-ligand: KL-1 and KL-2. Mol Biol Cell 3:349, 1992
33. Anderson DM, Lyman SD, Baird A, Wignall JM, Eisenman J, Rauch C, March CJ, Boswell HS, Gimpel SD, Cosman D, Williams DE: Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms. Cell 63:235, 1990
34. Toksoz D, Zsebo KM, Smith KA, Hu S, Brankow D, Suggs SV, Martin FH, Williams DA: Support of human hematopoiesis in long-term bone marrow cultures by murine stromal cells selectively expressing the membrane-bound and secreted forms of the human homolog of the steel gene product, stem cell factor. Proc Natl Acad Sci USA 89:7350, 1992
35. Huang EJ, Manova K, Packer AI, Sanchez S, Bachvarova RF, Besmer P: The murine steel panda mutation affects kit ligand expression and growth of early ovarian follicles. Dev Biol 157:100, 1993
36. d Sertoli cells is defective and is rescued by expression of the transmembrane form of the c-kit ligand. Dev Biol 157:182, 1993
37. Majumdar MK, Feng L, Medlock E, Toksoz D, Williams DA: Identification and mutation of primary and secondary proteolytic cleavage sites in murine stem cell factor cDNA yields biologically active, cell-associated protein. J Biol Chem 269:1237, 1994
38. Pandiella A, Bosenberg MW, Huang EJ, Besmer P, Massagué J: Cleavage of membrane-anchored growth factors involves distinct protease activities regulated through common mechanisms. J Biol Chem 267:24028, 1992
39. Arribas J, Coodly L, Vollmer P, Kishimoto TK, Rose-John S, Massagué J: Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors. J Biol Chem 271:11376, 1996
40. Broudy VC, Kovach NL, Bennett LG, Lin N, Jacobsen FW, Kidd PG: Human umbilical vein endothelial cells display high-affinity c-kit receptors and produce a soluble form of the c-kit receptor. Blood 83:2145, 1994
41. Longley BJ Jr, Morganroth GS, Tyrrell L, Ding TG, Anderson DM, Williams DE, Halaban R: Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis. N Engl J Med 328:1302, 1993
42. Klimpel GR, Chopra AK, Langley KE, Wypych J, Annable CA, Kaiserlian D, Ernst PB, Peterson JW: A role for stem cell factor and c-kit in the murine intestinal tract secretory response to cholera toxin. J Exp Med 182:1931, 1995
43. Klimpel GR, Langley KE, Wypych J, Abrams JS, Chopra AK, Niesel DW: A role for stem cell factor (SCF): c-kit interaction(s) in the intestinal tract response to Salmonella typhimurium infection. J Exp Med 184:271, 1996
44. - (triple-negative) thymocytes. Exp Hematol 22:1025, 1994
45. d mutant mice. Development 113:1031, 1991
46. Manova K, Huang EJ, Angeles M, De Leon V, Sanchez S, Pronovost SM, Besmer P, Bachvarova RF: The expression pattern of the c-kit ligand in gonads of mice supports a role for the c-kit receptor in oocyte growth and in proliferation of spermatogonia. Development 157:85, 1993
47. Manova K, Bachvarova RF, Huang EJ, Sanchez S, Pronovost SM, Velazquez E, McGuire B, Besmer P: c-kit receptor and ligand expression in postnatal development of the mouse cerebellum suggests a function for c-kit in inhibitory interneurons. J Neurosci 12:4663, 1992
48. + marrow cells. Blood 86:2161, 1995
49. Broudy VC, Kaushansky K, Harlan JM, Adamson JW: Interleukin-1 stimulates human endothelial cells to produce granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor. J Immunol 139:464, 1987
50. Heinrich MC, Dooley DC, Keeble WW: Transforming growth factor 1 inhibits expression of the gene products for steel factor and its receptor (c-kit). Blood 85:1769, 1995
51. Langley KE, Bennett LG, Wypych J, Yancik SA, Liu X-D, Westcott KR, Chang DG, Smith KA, Zsebo KM: Soluble stem cell factor in human serum. Blood 81:656, 1993
52. Wodnar-Filipowicz A, Yancik S, Moser Y, dalle Carbonare V, Gratwohl A, Tichelli A, Speck B, Nissen C: Levels of soluble stem cell factor in serum of patients with aplastic anemia. Blood 81:3259, 1993
53. Bowen D, Yancik S, Bennett L, Culligan D, Resser K: Serum stem cell factor concentration in patients with myelodysplastic syndromes. Br J Haematol 85:63, 1993
54. Abkowitz JL, Hume H, Yancik SA, Bennett LG, Matsumoto AM: Stem cell factor serum levels may not be clinically relevant. Blood 87:4017, 1996
55. Testa U, Martucci R, Rutella S, Scambia G, Sica S, Panici PB, Pierelli L, Menichella G, Leone G, Mancuso S, Peschle C: Autologous stem cell transplantation: Release of early and late acting growth factors relates with hematopoietic ablation and recovery. Blood 84:3532, 1994
56. Hunt P, Zsebo KM, Hokom MM, Hornkohl A, Birkett NC, del Castillo JC, Martin F: Evidence that stem cell factor is involved in the rebound thrombocytosis that follows 5-Fluorouracil treatment. Blood 80:904, 1992
57. Limmani A, Baker WH, Chang CM, Seemann R, Williams DE, Patchen ML: c-kit ligand gene expression in normal and sublethally irradiated mice. Blood 85:2377, 1995
58. Arakawa T, Yphantis DA, Lary JW, Narhi LO, Lu HS, Prestrelski SJ, Clogston CL, Zsebo KM, Mendiaz EA, Wypych J, Langley KE: Glycosylated and unglycosylated recombinant-derived human stem cell factors are dimeric and have extensive regular secondary structure. J Biol Chem 266:18942, 1991
59. Zsebo KM, Wypych J, McNiece IK, Lu HS, Smith KA, Karkare SB, Sachdev RK, Yuschenkoff VN, Birkett NC, Williams LR, Satyagal VN, Tung W, Bosselman RA, Mendiaz EA, Langley KE: Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat liver-conditioned medium. Cell 63:195, 1990
60. Lu HS, Clogston CL, Wypych J, Fausset PR, Lauren S, Mendiaz EA, Zsebo KM, Langley KE: Amino acid sequence and posttranslational modification of stem cell factor isolated from Buffalo rat liver cell-conditioned medium. J Biol Chem 266:8102, 1991
61. Lu HS, Clogston CL, Wypych J, Parker VP, Lee TD, Swiderek K, Baltera RF Jr, Patel AC, Chang DC, Brankow DW, Liu X-D, Ogden SG, Karkare SB, Hu SS, Zsebo KM, Langley KE: Post-translational processing of membrane-associated recombinant human stem cell factor expressed in Chinese hamster ovary cells. Arch Biochem Biophys 298:150, 1992
62. Langley KE, Wypych J, Mendiaz EA, Clogston CL, Parker VP, Farrar DH, Brothers MO, Satygal VN, Leslie I, Birkett NC, Smith KA, Baltera RF Jr, Lyons DE, Hogan JM, Crandall C, Boone TC, Pope JA, Karkare SB, Zsebo KM, Sachdev RK, Lu HS: Purification and characterization of soluble forms of human and rat stem cell factor recombinantly expressed by Escherichia coli and by Chinese hamster ovary cells. Arch Biochem Biophys 295:21, 1992
63. Nishikawa M, Tojo A, Ikebuchi K, Katayama K, Fujii N, Ozawa K, Asano S: Deletion mutagenesis of stem cell factor defines the c-terminal sequences essential for its biological activity. Biochem Biophys Res Commun 188:292, 1992
64. Jones MD, Narhi LO, Chang W-C, Lu HS: Refolding and oxidation of recombinant human stem cell factor produced in Escherichia coli. J Biol Chem 271:11301, 1996
65. Lu HS, Jones MD, Shieh J-H, Mendiaz EA, Feng D, Walter P, Narhi LO, Langley KE: Isolation and characterization of a disulfidelinked human stem cell factor dimer. J Biol Chem 271:11309, 1996
66. Bazan JF: Genetic and structural homology of stem cell factor and macrophage colony-stimulating factor. Cell 65:9, 1991
67. Yarden Y, Kuang W-J, Yang-Feng T, Coussens L, Munemitsu S, Dull TJ, Chen E, Schlessinger J, Francke U, Ullrich A: Human proto-oncogene c-kit: A new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 6:3341, 1987
68. Qiu F, Ray P, Brown K, Barker PE, Jhanwar S, Ruddle FH, Besmer P: Primary structure of c-kit: Relationship with the CSF-1/ PDGF receptor kinase family-oncogenic activation of v-kit involves deletion of extracellular domain and C terminus. EMBO J 7:1003, 1988
69. Pandit J, Bohm A, Jancarik J, Halenbeck R, Koths K, Kim S-H: Three-dimensional structure of dimeric human recombinant macrophage colony-stimulating factor. Science 258:1358, 1992
70. Martin FH, Suggs SV, Langley KE, Lu HS, Ting J, Okino KH, Morris CF, McNiece IK, Jacobsen FW, Mendiaz EA, Birkett NC, Smith KA, Johnson MJ, Parker VP, Flores JC, Patel AC, Fisher EF, Erjavec HO, Herrera CJ, Wypych J, Sachdev RK, Pope JA, Leslie I, Wen D, Lin C-H, Cupples RL, Zsebo KM: Primary structure and functional expression of rat and human stem cell factor DNAs. Cell 63:203, 1990
71. Lev S, Yarden Y, Givol D: Dimerization and activation of the Kit receptor by monovalent and bivalent binding of the stem cell factor. J Biol Chem 267:15970, 1992
72. Matous JV, Langley K, Kaushansky K: Structure-function relationships of stem cell factor: An analysis based on a series of human-murine stem cell factor chimera and the mapping of a neutralizing monoclonal antibody. Blood 88:437, 1996
73. 17H mice result from a splicing defect in the steel factor cytoplasmic tail. Genes Dev 6:1832, 1992
74. Langley KE, Mendiaz EA, Liu N, Narhi LO, Zeni L, Parseghian CM, Clogston CL, Leslie I, Pope JA, Lu HS, Zsebo KM: Properties of variant forms of human stem cell factor recombinantly expressed in Escherchia coli. Arch Biochem Biophys 311:55, 1994
75. Russell ES, Bernstein SE, Lawson FA, Smith LJ: Long-continued function of normal blood-forming tissue transplanted into genetically anemic hosts. J Natl Cancer Inst 23:557, 1959
76. Dexter TM, Moore MAS: In vitro duplication and 'cure' of haemopoietic defects in genetically anaemic mice. Nature 269:412, 1977
77. Bernstein SE: Tissue transplantation as an analytic and therapeutic tool in hereditary anemias. Am J Surg 119:448, 1970
78. Wolf NS: Dissecting the hematopoietic microenvironment. III. Evidence for a short range stimulus for cellular proliferation. Cell Tissue Kinet 11:335, 1978
79. v. Science 144:844, 1964
80. v marrow. Blood 30:601, 1967
81. d mice, in Hibino S, Takaku F, Shahidi NT (eds): Aplastic Anemia. Baltimore, MD, University Park, 1978
82. Gregory CJ, Eaves AC: Three stages of erythropoietic progenitor cell differentiation distinguished by a number of physical and biologic properties. Blood 51:527, 1978
83. d hematopoietic progenitors are deficient in situ. Exp Hematol 22:174, 1994
84. 0 and entry into the cell cycle of primitive human hemopoietic progenitors. Proc Natl Acad Sci USA 89:4013, 1992
85. Li CL, Johnson GR: Stem cell factor enhances the survival but not the self-renewal of murine hematopoietic long-term repopulating cells. Blood 84:408, 1994
86. + cells in serum-free cultures containing Steel factor, interleukin-6, and erythropoietin with maintenance of cells with long-term in vivo reconstituting potential. Blood 83:128, 1994
87. Wineman JP, Nishikawa S-I, Müller-Sieburg CE: Maintenance of high levels of pluripotent hematopoietic stem cells in vitro: Effect of stromal cells and c-kit. Blood 81:365, 1993
88. Peters SO, Kittler ELW, Ramshaw HS, Quesenberry PJ: Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts. Blood 87:30, 1996
89. Hirayama F, Clark SC, Ogawa M: Negative regulation of early B lymphopoiesis by interleukin 3 and interleukin 1α. Proc Natl Acad Sci USA 91:469, 1994
90. Hirayama F, Ogawa M: Negative regulation of early T lymphopoiesis by interleukin-3 and interleukin-1α. Blood 86:4527, 1995
91. Yonemura Y, Ku H, Hirayama F, Souza LM, Ogawa M: Interleukin 3 or interleukin 1 abrogates the reconstituting ability of hematopoietic stem cells. Proc Natl Acad Sci USA 93:4040, 1996
92. Holyoake TL, Freshney MG, McNair L, Parker AN, McKay PJ, Steward WP, Fitzsimons E, Graham GJ, Pragnell IB: Ex vivo expansion with stem cell factor and interleukin-11 augments both short-term recovery posttransplant and the ability to serially transplant marrow. Blood 87:4589, 1996
93. Miller CL, Rebel VI Helgason CD, Lansdorp PM, Eaves CJ: Impaired steel factor responsiveness differentially affects the detection and long-term maintenance of fetal liver hematopoietic stem cells in vivo. Blood 89:1214, 1997
94. de Vries P, Brasel KA, Eisenman JR, Alpert AR, Williams DE: The effect of recombinant mast cell growth factor on purified murine hematopoietic stem cells. J Exp Med 173:1205, 1991
95. Kodama H, Nose M, Yamaguchi Y, Tsunoda J, Suda T, Nishikawa S, Nishikawa S: In vitro proliferation of primitive hemopoietic stem cells supported by stromal cells: Evidence for the presence of a mechanism(s) other than that involving c-kit receptor and its ligand. J Exp Med 176:351, 1992
96. Sutherland HJ, Hogge DE, Cook D, Eaves CJ: Alternative mechanisms with and without steel factor support primitive human hematopoiesis. Blood 81:1465, 1993
97. Petzer AL, Hogge DE, Lansdorp PM, Reid DS, Eaves CJ: Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium. Proc Natl Acad Sci USA 93:1470, 1996
98. - cells cultured with interleukin-3, granulocyte colony-stimulating factor, or granulocyte-macrophage colony-stimulating factor. Blood 77:2316, 1991
99. + cord blood cells in the presence of recombinant human stem cell factor. Blood 79:2620, 1992
100. + cells into the myeloid lineage. Blood 80:1405, 1992
101. Brandt J, Briddell RA, Srour EF, Leemhuis TB, Hoffman R: Role of c-kit ligand in the expansion of human hematopoietic progenitor cells. Blood 79:634, 1992
102. + progenitor cells by stem cell factor, interleukin-1β (IL-1β), IL-6, IL-3, interferon-γ, and eryrhropoietin. Blood 81:2579, 1993
103. +-selected human peripheral blood progenitor cells. Blood 84:2898, 1994
104. Brugger W, Heimfeld S, Berenson RJ, Mertelsmann R, Kanz L: Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N Engl J Med 333:283, 1995
105. + cells. Blood 82:3600, 1993
106. + cells from patients with stage IV breast cancer. Blood 84:3567, 1994
107. Sui X, Tsuji K, Tanaka R, Tajima S, Muraoka K, Ebihara Y, Ikebuchi K, Yasukawa K, Taga T, Kishimoto T, Nakahata T: gp130 and c-Kit signalings synergize for ex vivo expansion of human primitive hemopoietic progenitor cells. Proc Natl Acad Sci USA 92:2859, 1995
108. Kobayashi M, Laver JH, Kato T, Miyazaki H, Ogawa M: Thrombopoietin supports proliferation of human primitive hematopoietic cells in synergy with steel factor and/or interleukin-3. Blood 88:429, 1996
109. Nocka K, Buck J, Levi E, Besmer P: Candidate ligand for the c-kit transmembrane kinase receptor: KL, a fibroblast derived growth factor stimulates mast cells and erythroid progenitors. EMBO J 9:3287, 1990
110. Broxmeyer HE, Hangoc G, Cooper S, Anderson D, Cosman D, Lyman SD, Williams DE: Influence of murine mast cell growth factor (c-kit ligand) on colony formation by mouse marrow hematopoietic progenitor cells. Exp Hematol 19:143, 1991
111. McNiece IK, Langley KE, Zsebo KM: Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and Epo to stimulate human progenitor cells of the myeloid and erythroid lineages. Exp Hematol 19:226, 1991
112. Broxmeyer HE, Cooper S, Lu L, Hangoc G, Anderson D, Cosman D, Lyman SD, Williams DE: Effect of murine mast cell growth factor (c-kil proto-oncogene ligand) on colony formation by human marrow hematopoietic progenitor cells. Blood 77:2142, 1991
113. Migliaccio G, Migliaccio AR, Druzin ML, Giardina P-JV, Zsebo KM, Adamson JW: Effects of recombinant human stem cell factor (SCF) on the growth of human progenitor cells in vitro. J Cell Physiol 148:503, 1991
114. Metcalf D, Nicola NA: Direct proliferative actions of stem cell factor on murine bone marrow cells in vitro: Effects of combination with colony-stimulating factors. Proc Natl Acad Sci USA 88:6239, 1991
115. - cells. Exp Hematol 22:919, 1994
116. Fahlman C, Blomhoff HK, Veiby OP, McNiece IK, Jacobsen SEW: Stem cell factor and interleukin-7 synergize to enhance early myelopoiesis in vitro. Blood 84:1450, 1994
117. Keller JR, Ortiz M, Ruscetti FW: Steel factor (c-kit ligand) promotes the survival of hematopoietic stem/progenitor cells in the absence of cell division. Blood 86:1757, 1995
118. Dai CH, Krantz SB, Zsebo KM: Human burst-forming units-erythroid need direct interaction with stem cell factor for further development. Blood 78:2493, 1991
119. Papayannopoulou T, Brice M, Blau CA: Kit ligand in synergy with interleukin-3 amplifies the erythropoietin-independent, globin-synthesizing progeny of normal human burst-forming units-erythroid in suspension cultures: Physiologic implications. Blood 81:299, 1993
120. Nocka K, Majumder S, Chabot B, Ray P, Cervone M, Bernstein A, Besmer P: Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice-evidence for an impaired c-kit kinase in mutant mice. Genes Dev 3:816, 1989
121. de Wolf JTM, Muller EW, Hendriks DH, Halie RM, Vellenga E: Mast cell growth factor modulates CD36 antigen expression on erythroid progenitors from human bone marrow and peripheral blood associated with ongoing differentiation. Blood 84:59, 1994
122. Muta K, Krantz SB, Bondurant MC, Wickrema A: Distinct roles of erythropoietin, insulin-like growth factor I, and stem cell factor in the development of erythroid progenitor cells. J Clin Invest 94:34, 1994
123. Wu H, Klingmüller U, Besmer P, Lodish HF: Interaction of the erythropoietin and stem-cell-factor receptors. Nature 377:242, 1995
124. Wu H, Klingmüller U, Acurio A, Hsiao JG, Lodish HF: Functional interaction of erythropoietin and stem cell factor receptors is essential for erythroid colony formation. Proc Natl Acad Sci USA 94:1806, 1997
125. + cells. J Exp Med 183:837, 1996
126. Peschle C, Gabbianelli M, Testa U, Pelosi E, Barben T, Fossati C, Valtieri M, Leone L: c-kit ligand reactivates fetal hemoglobin synthesis in serum-free culture of stringently purified normal adult burst-forming unit-erythroid. Blood 81:328, 1993
127. Muta K, Krantz SB, Bondurant MC, Dai C-H: Stem cell factor retards differentiation of normal human erythroid progenitor cells while stimulating proliferation. Blood 86:572, 1995
128. Okumura N, Tsuji K, Ebihara Y, Tanaka I, Sawai N, Koike K, Komiyama A, Nakahata T: Chemotactic and chemokinetic activities of stem cell factor on murine hematopoietic progenitor cells. Blood 87:4100, 1996
129. Broudy VC, Lin NL, Kaushansky K: Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro. Blood 85:1719, 1995
130. Briddell RA, Bruno E, Cooper RJ, Brandt JE, Huffman R: Effect of c-kit ligand on in vitro human megakaryocytopoiesis. Blood 78:2854, 1991
131. Avraham H, Vannier E, Cowley S, Jiang S, Chi S, Dinarello CA, Zsebo KM, Groopman JE: Effects of the stem cell factor, c-kit ligand, on human megakaryocytic cells. Blood 79:365, 1992
132. + cells. Blood 82:84, 1993
133. Grabarek J, Groopman JE, Lyles YR, Jiang S, Bennett L, Zsebo K, Avraham H: Human kit ligand (stem cell factor) modulates platelet activation in vitro. J Biol Chem 269:21718, 1994
134. v mice and their increase by bone marrow transplantation. Blood 52:447, 1978
135. d anemic mice. Blood 53:492, 1979
136. v. J Cell Physiol 122:187, 1985
137. d fibroblasts do not support development of normal mast cell-committed progenitors. J Immunol 142:2418, 1989
138. Tsai M, Takeishi T, Thompson H, Langley KE, Zsebo KM, Metcalfe DD, Geissler EN, Galli SJ: Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. Proc Natl Acad Sci USA 88:6382, 1991
139. Iemura A, Tsai M, Ando A, Wershil BK, Galli SJ: The c-kit ligand, stem cell factor, promotes mast cell survival by suppressing apoptosis. Am J Pathol 144:321, 1994
140. Rodewald H-R, Dessing M, Dvorak AM, Galli SJ: Identification of a committed precursor for the mast cell lineage. Science 271:818, 1996
141. + pluripotent progenitor cells. J Immunol 148:772, 1992
142. Valent P, Spanblöchl E, Sperr WR, Sillaber C, Zsebo KM, Agis H, Strobl H, Geissler K, Bettelheim P, Lechner K: Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture. Blood 80:2237, 1992
143. + cord blood cells stimulated with stem cell factor and interleukin-3. Blood 84:3667, 1994
144. Irani A-MA, Nilsson G, Miettinen U, Craig SS, Ashman LK, Ishizaka T, Zsebo KM, Schwarrz LB: Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells. Blood 80:3009, 1992
145. Haig DM, Huntley JF, MacKellar A, Newlands GFJ, Inglis L, Sangha R, Cohen D, Hapel A, Galli SJ, Miller HRP: Effects of stem cell factor (Kit-ligand) and interleukin-3 on the growth and serine proteinase expression of rat bone marrow-derived or serosal mast cells. Blood 83:72, 1994
146. Rennick D, Hunte B, Holland G, Thompson-Snipes L: Co-factors are essential for stem cell factor-dependent growth and maturation of mast cell progenitors: Comparative effects of interleukin-3 (IL-3), IL-4, IL-10, and fibroblasts. Blood 85:57, 1995
147. Wershil BK, Tsai M, Geissler EN, Zsebo KM, Galli SJ: The rat c-kit ligand, stem cell factor, induces c-kit receptor-dependent mouse mast cell activation in vivo. evidence that signaling through the c-kit receptor can induce expression of cellular function. J Exp Med 175:245, 1992
148. Columbo M, Horowitz EM, Botana LM, MacGlashan DW Jr, Bochner BS, Gillis S, Zsebo KM, Galli SJ, Lichtenstein LM: The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. J Immunol 149:599, 1992
149. Meininger CJ, Yano H, Rottapel R, Bernstein A, Zsebo KM, Zetter BR: The c-kit receptor ligand functions as a mast cell chemoat-tractant. Blood 79:958, 1992
150. Dastych J, Metcalfe DD: Stem cell factor induces mast cell adhesion to fibronectin. J Imrnunol 152:213, 1994
151. Bischoff SC, Dahinden CA: c-kit ligand: A unique potentiator of mediator release by human lung mast cells. J Exp Med 175:237, 1992
152. Gagari E, Tsai M, Lantz CS, Fox LG, Galli SJ: Differential release of mast cell interleukin-6 via c-kit. Blood 89:2654, 1997
153. Galli SJ, Iemura A, Garlick DS, Gamba-Vitalo C, Zsebo KM, Andrews RG:
154. Tsai M, Shih L-S, Newlands GFJ, Takeishi T, Langley KE, Zsebo KM, Miller HRP, Geissler EN, Galli SJ: The rat c-kit ligand, stem cell factor, induces the development of connective tissue-type and mucosal mast cells in vivo. Analysis by anatomical distribution, histochemistry, and protease phenotype. J Exp Med 174:125, 1991
155. Costa JJ, Demetri GD, Harrist TJ, Dvorak AM, Hayes DF, Merica EA, Menchaca DM, Gringeri AJ, Schwartz LB, Galli SJ: Recombinant human stem cell factor (Kit ligand) promotes human mast cell and melanocyte hyperplasia and funcational activation in vivo. J Exp Med 183:2681, 1996
156. Opstelten D, Osmond DG: Regulation of pre-B cell proliferation in bone marrow: Immunofluorescence stathmokinetic studies of cytoplasmic μ chain-bearing cells in anti-IgM-treated mice, hematologically deficient mutant mice and mice given sheep red blood cells. Eur J Immunol 15:599, 1985
157. Landreth KS, Kincade PW, Lee G, Harrison DE: B lymphocyte precursors in embryonic and adult W anemic mice. J Immunol 132:2724, 1984
158. Rico-Vargas SA, Weiskopf B, Nishikawa S-I, Osmond DG: c-kit expression by B cell precursors in mouse bone marrow. J Immunol 152:2845, 1994
159. Takeda S, Shimizu S, Rodewald H-R: Interactions between c-kit and stem cell factor are not required for B-cell development in vivo. Blood 89:518, 1997
160. Rolink A, Melchers F: Molecular and cellular origins of B lymphocyte diversity. Cell 66:1081, 1991
161. Hirayama F, Shih J-P, Awgulewitsch A, Warr GW, Clark SC, Ogawa M: Clonal proliferation of murine lymphohemopoietic progenitors in culture. Proc Natl Acad Sci USA 89:5907, 1992
162. Veiby OP, Lyman SD, Jacobsen SEW: Combined signaling through interleukin-7 receptors and flt3 but not c-kit potently and selectively promotes B-cell commitment and differentiation from uncommitted murine bone marrow progenitor cells. Blood 88:1256, 1996
163. Faust EA, Saffran DC, Toksoz D, Williams DA, Witte ON: Distinctive growth requirements and gene expression patterns distinguish progenitor B cells from pre-B cells. J Exp Med 177:915, 1993
164. Billips LG, Petitte D, Dorshkind K, Narayanan R, Chiu C-P, Landreth KS: Differential roles of stromal cells, interleukin-7, and kit-ligand in the regulation of B lymphopoiesis. Blood 79:1185, 1992
165. Rolink A, Streb M, Nishikawa S-I, Melchers F: The c-kit-encoded tyrosine kinase regulates the proliferation of early pre-B cells. Eur J Immunol 21:2609, 1991
166. Rodewald H-R, Kretzschmar K, Swat W, Takeda S: Intrathymically expressed c-kit ligand (stem cell factor) is a major factor driving expansion of very immature thymocytes in vivo. Immunity 3:313, 1995
167. Godfrey DI, Zlotnik A, Suda T: Phenotypic and functional characterization of c-kit expression during intrathymic T cell development. J Immunol 149:2281, 1992
168. Laky K, Lefrancois L, Puddington L: Age-dependent intestinal lymphoproliferative disorder due to stem cell factor receptor deficiency. J Immunol 158:1417, 1997
169. Bluman EM, Schnier GS, Avalos BR, Strout MP, Sultan H, Jacobson FW, Williams DE, Carson WE, Caligiuri MA: The c-kit ligand potentiates the allogeneic mixed lymphocyte reaction. Blood 88:3887, 1996
170. + hematopoietic progenitor cells. Blood 85:3538, 1995
171. Matos ME, Schnier GS, Beecher MS, Ashman LK, Williams DE, Caligiuri MA: Expression of a functional c-kit receptor on a subset of natural killer cells. J Exp Med 178:1079, 1993
172. Young JW, Szabolcs P, Moore MAS: Identification of dendritic cell colony-forming units among normal human CD34+ bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor α. J Exp Med 182:1111, 1995
173. Szabolcs P, Moore MAS, Young JW: Expansion of immunostimulatory dendritic cells among the myeloid progeny of human CD34+ bone maarrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-α. J Immunol 154:5851, 1995
174. Yoder MC, Williams DA: Matrix molecule interactions with hematopoietic stem cells. Exp Hematol 23:961, 1995
175. Rosemblatt M, Vuillet-Gaugler MH, Leroy C, Coulombel L: Coexpression of two fibronectin receptors, VLA-4 and VLA-5, by immature human erythroblastic precursor cells. J Clin Invest 87:6, 1991
176. Simmons PJ, Masinovsky B, Longenecker BM, Berenson R, Torok-Storb B, Gallatin WM: Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells. Blood 80:388, 1992
177. Verfaillie CM, McCarthy JB, McGlave PB: Differentiation of primitive human multipotent hematopoietic progenitors into single lineage clonogenic progenitors is accompanied by alterations in their interaction with fibronectin. J Exp Med 174:693, 1991
178. Williams DA, Rios M, Stephens C, Patel VP: Fibronectin and VLA-4 in haematopoietic stem cell-microenvironment interactions. Nature 352:438, 1991
179. Vuillet-Gaugler MH, Breton-Gorius J, Vainchenker W, Guichard J, Leroy C, Tchernia G, Coulombel L: Loss of attachment to fibronectin with terminal human erythroid differentiation. Blood 75:865, 1990
180. Hurley RW, McCarthy JB, Verfaillie CM: Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation. J Clin Invest 96:511, 1995
181. Healy L, May G, Gale K, Grosveld F, Greaves M, Enver T: The stem cell antigen CD34 functions as a regulator of hemopoietic cell adhesion. Proc Natl Acad Sci USA 92:12240, 1995
182. Kinashi T, Springer TA: Steel factor and c-kit regulate cell-matrix adhesion. Blood 83:1033, 1994
183. Kaneko Y, Takenawa J, Yoshida O, Fujita K, Sugimoto K, Nakayama H, Fujita J: Adhesion of mouse mast cells to fibroblasts: Adverse effects of steel (Sl) mutation. J Cell Physiol 147:224, 1991
184. Adachi S, Ebi Y, Nishikawa S, Hayashi S, Yamazaki M, Kusugai T, Yamamura T, Nomura S, Kitamura Y: Necessity of extracellular domain of W (c-kit) receptors for attachment of murine cultured mast cells to fibroblasts. Blood 79:650, 1992
185. Serve H, Yee NS, Stella G, Sepp-Lorenzino L, Tan JC, Besmer P: Differential roles of P13-kinase and Kit tyrosine 821 in Kit receptor-mediated proliferation, survival and cell adhesion in mast cells. EMBO J 14:473, 1995
186. 1 integrins expressed on hematopoietic cell lines. Blood 85:159, 1995
187. Lévesque J-P, Leavesley DI, Niutta S, Vadas M, Simmons PJ: Cytokines increase human hemopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins. J Exp Med 181:1805, 1995
188. + hemopoietic progenitors. Blood 88:1168, 1996
189. Kodama H, Nose M, Niida S, Nishikawa S, Nishikawa S-I: Involvement of the c-kit receptor in the adhesion of hematopoietic stem cells to stromal cells. Exp Hematol 22:979, 1994
190. Avraham H, Scadden DT, Chi S, Broudy VC, Zsebo KM, Groopman JE: Interaction of human bone marrow fibroblasts with megakaryocytes: Role of the c-kit ligand. Blood 80:1679, 1992
191. FAK) and paxillin. Blood 89:1574, 1997
192. d mice. Exp Hematol 20:807, 1992 (abstr)
193. d mice. Blood 77:1691, 1991
194. Blume-Jensen P, Claesson-Welsh L, Siegbahn A, Zsebo KM, Westermark B, Heldin C-H: Activation of the human c-kit product by ligand-induced dimerization mediates circular actin reorganization and chemotaxis. EMBO J 10:4121, 1991
195. Fleming WH, Alpern EJ, Uchida N, Ikuta K, Weissman IL: Steel factor influences the distribution and activity of murine hematopoietic stem cells in vivo. Proc Natl Acad Sci USA 90:3760, 1993
196. Yan X-Q, Briddell R, Hartley C, Stoney G, Samal B, McNiece I: Mobilization of long-term hematopoietic reconstituting cells in mice by the combination of stem cell factor plus granulocyte colony-stimulating factor. Blood 84:795, 1994
197. + colony-forming cell types in blood and marrow of baboons. Blood 80:920, 1992
198. Andrews RG, Bensinger WI, Knitter GH, Bartelmez SH, Longin K, Bernstein ID, Appelbaum FR, Zsebo KM: The ligand for c-kit, stem cell factor, stimulates the circulation of cells that engraft lethally irradiated baboons. Blood 80:2715, 1992
199. 4 integrin. Proc Natl Acad Sci USA 90:9374, 1993
200. 4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen. Proc Natl Acad Sci USA 92:9647, 1995
201. Carlos TM, Harlan JM: Leukocyte-endothelial adhesion molecules. Blood 84:2068, 1994
202. Tong J, Gordon MS, Srour EF, Cooper RJ, Orazi A, McNiece I, Hoffman R: In vivo administration of recombinant methionyl human stem cell factor expands the number of human marrow hematopoietic stem cells. Blood 82:784, 1993
203. Weaver A, Ryder D, Crowther D, Dexter TM, Testa NG: Increased numbers of long-term culture-initiating cells in the apheresis product of patients randomized to receive increasing doses of stem cell factor administered in combination with chemotherapy and a standard dose of granulocyte colony-stimulating factor. Blood 88:3323, 1996
204. d mice as a single factor. Blood 79:913, 1992
205. Molineux G, Migdalska A, Szmitkowski M, Zsebo K, Dexter TM: The effects on hematopoiesis of recombinant stem cell factor (ligand for c-kit) administered in vivo to mice either alone or in combination with granulocyte colony-stimulating factor. Blood 78:961, 1991
206. Bodine DM, Seidel NE, Zsebo KM, Orlic D: In vivo administration of stem cell factor to mice increases the absolute number of pluripotent hematopoietic stem cells. Blood 82:445, 1993
207. Harrison DE, Zsebo KM, Astle CM: Splenic primitive hematopoietic stem cell (PHSC) activity is enhanced by steel factor because of PHSC proliferation. Blood 83:3146, 1994
208. Bodine DM, Seidel NE, Gale MS, Nienhuis AW, Orlic D: Efficient retrovirus transduction of mouse pluripotent hematopoietic stem cells mobilized into the peripheral blood by treatment with granulocyte colony-stimulating factor and stem cell factor. Blood 84:1482, 1994
209. Dunbar CE, Seidel NE, Doren S, Sellers S, Cline AP, Metzger ME, Agricola BA, Donahue RE, Bodine DM: Improved retroviral gene transfer into murine and rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor. Proc Natl Acad Sci USA 93:11871, 1996
210. Yan X-Q, Hartley C, McElroy P, Chang A, McCrea C, McNiece I: Peripheral blood progenitor cells mobilized by recombinant human granulocyte colony-stimulating factor plus recombinant rat stem cell factor contain long-term engrafting cells capable of cellular proliferation for more than two years as shown by serial transplantation in mice. Blood 85:2303, 1995
211. Andrews RG, Briddell RA, Knitter GH, Rowley SD, Appelbaum FR, McNiece IK: Rapid engraftmem by peripheral blood progenitor cells mobilized by recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in nonhuman primates. Blood 85:15, 1995
212. Russell ES, Bernstein SE, McFarland EC, Modeen WR: The cellular basis of differential radiosensitivity of normal and genetically anemic mice. Radiat Res 20:677, 1963
213. Yee NS, Paek I, Besmer P: Role of to-ligand in proliferation and suppression of apoptosis in mast cells: Basis tor radiosensitivity of White Spotting and Steel mutant mice. J Exp Med 179:1777, 1994
214. Zsebo KM, Smith KA, Hartley CA, Greenblatt M, Cooke K, Rich W, McNiece IK: Radioprotection of mice by recombinant rat stem cell factor. Proc Natl Acad Sci USA 89:9464, 1992
215. Leigh BR, Khan W, Hancock SL, Knox SJ: Stem cell factor enhances the survival of murine intestinal stem cells after photon irradiation. Radial Res 142:12, 1995
216. Patchen ML, Fischer R, Schmauder-Chock EA, Williams DE: Mast cell growth factor enhances multilineage hematopoietic recovery in vivo following radiation-induced aplasia. Exp Hematol 22:31, 1994
217. Schuening FG, Appelbaum FR, Deeg HJ, Sullivan-Pepe M, Graham TC, Hackman R, Zsebo KM, Storb R: Effects of recombinant canine stem cell factor, a c-kit ligand, and recombinant granulocyte colony-stimulating factor on hematopoietic recovery after otherwise lethal total body irradiation. Blood 81:20, 1993
218. Neta R, Williams D, Selzer F, Abrams J: Inhibition of c-kit ligand/steel factor by antibodies reduces survival of lethally irradiated mice. Blood 81:324, 1993
219. Molineux G, Migdalska A, Haley J, Evans GS, Dexter TM: Total marrow failure induced by pegylated stem-cell factor administered before 5-Fluorouracil. Blood 83:3491, 1994
220. Du XX, Keller D, Maze R, Williams DA: Comparative effects of in vivo treatment using interleukin-11 and stem factor on reconstitution in mice after bone marrow transplantation. Blood 82:1016, 1993
221. Storb R, Raff RF, Appelbaum FR, Deeg HJ, Graham TC, Schuening FG, Shulman H, Yu C, Bryant E, Burnett R, Seidel K: DLA-identical bone marrow grafts after low-dose total body irradiation. The effect of canine recombinant hematopoietic growth factors. Blood 84:3558, 1994
222. Dolci S, Williams DE, Ernst MK, Resnick JL, Brannan CI, Lock LF, Lyman SD, Boswell HS, Donovan PJ: Requirement for mast cell growth factor for primordial germ cell survival in culture. Nature 352:809, 1991
223. Matsui Y, Toksoz D, Nishikawa S, Nishikawa S-I, Williams D, Zsebo K, Hogan BLM: Effect of steel factor and leukaemia inhibitory factor on murine primordial germ cells in culture. Nature 353:750, 1991
224. Miyazawa K, Williams DA, Gotoh A, Nishimaki J, Broxmeyer HE, Toyama K: Membrane-bound steel factor induces more persistent tyrosine kinase activation and longer life span of c-kit gene-encoded protein than its soluble form. Blood 85:641, 1995
225. Marshall CJ: Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179, 1995
226. Majumdar MK, Everett ET, Xiao X, Cooper R, Langley K, Kapur R, Vik T, Williams DA: Xenogeneic expression of human stem cell factor in transgenic mice mimics codominant c-kit mutations. Blood 87:3203, 1996
227. Kapur R, Majumdar MK, Xiao X, Schindler K, McAndrews-Hill M, Williams DA: Transgenic expression of stem cell factor in Steel-dickie mice: Delineation of a unique in vivo role of membrane-associated protein in erythropoiesis. Blood 88:473a, 1996 (abstr, suppl 1)
228. Wehrle-Haller B, Weston JA: Soluble and cell-bound forms of steel factor activity play distinct roles in melanocyte precursor dispersal and survival on the lateral neural crest migration pathway. Development 121:731, 1995
229. Besmer P, Murphy JE, George PC, Qiu F, Bergold PJ, Lederman L, Snyder HW Jr, Brodeur D, Zuckerman EE, Hardy WD: A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family. Nature 320:415, 1986
230. Ullrich A, Schlessinger J: Signal transduction by receptors with tyrosine kinase activity. Cell 61:203, 1990
231. Heldin C-H: Dimerization of cell surface receptors in signal transduction. Cell 80:213, 1995
232. Paulson RF, Vesely S, Siminovitch KA, Bernstein A: Signalling by the W/Kit receptor tyrosine kinase is negatively regulated in vivo by the protein tyrosine phosphatase Shp1. Nat Genet 13:309, 1996
233. Lorenz U, Bergemann AD, Steinherg HN, Flanagan JG, Li X, Galli SJ, Neel BG: Genetic analysis reveals cell type-specific regulation of receptor tyrosine kinase c-kit by the protein tyrosine phosphatase SHP1. J Exp Med 184:1111, 1996
234. Blechman JM, Lev S, Brizzi MF, Leitner O, Pegoraro L, Givol D, Yarden Y: Soluble c-Kit proteins and antireceptor monoclonal antibodies confine the binding site of the stem cell factor. J Biol Chem 268:4399, 1993
235. Lev S, Blechman J, Nishikawa S-I, Givol D, Yarden Y: Interspecies molecular chimeras of Kit help define the binding site of the stem cell factor. Mol Cell Biol 13:2224, 1993
236. Blechman JM, Lev S, Barg J, Eisenstein M, Vaks B, Vogel Z, Givol D, Yarden Y: The fourth immunoglobulin domain of the stem cell factor receptor couples ligand binding to signal transduction. Cell 80:103, 1995
237. Lev S, Yarden Y, Givol D: A recombinant ectodomain of the receptor for the stem cell factor (SCF) retains ligand-induced receptor dimerization and antagonizes SCF-stimulated cellular responses. J Biol Chem 267:10866, 1992
238. Turner AM, Bennett LG, Lin NL, Wypych J, Bartley TD, Hunt RW, Atkins HL, Langley KE, Parker V, Martin F, Broudy VC: Identification and characterization of a soluble c-kit receptor produced by human hematopoietic cell lines. Blood 85:2052, 1995
239. Philo JS, Wen J, Wypych J, Schwartz MG, Mendiaz EA, Langley KE: Human stem cell factor dimer forms a complex with two molecules of the extracellular domain of its receptor, Kit. J Biol Chem 271:6895, 1996
240. Reith AD, Ellis C, Lyman SD, Anderson DM, Williams DE, Bernstein A, Pawson T: Signal transduction by normal isoforms and W mutant variants of the Kit receptor tyrosine kinase. EMBO J 10:2451, 1991
241. Piao X, Curtis JE, Minkin S, Minden MD, Bernstein A: Expression of the Kit and KitA receptor isoforms in human acute myelogenous leukemia. Blood 83:476, 1994
242. Furitsu T, Tsujimura T, Tono T, Ikeda H, Kitayama H, Koshimizu U, Sugahara H, Butterfield JH, Ashman LK, Kanayama Y, Matsuzawa Y, Kitamura Y, Kanakura Y: Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest 92:1736, 1993
243. Tsujimura T, Furitsu T, Morimoto M, Isozaki K, Nomura S, Matsuzawa Y, Kitamura Y, Kanakura Y: Ligand-independent activation ot c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation. Blood 83:2619, 1994
244. Hashimoto K, Tsujimura T, Moriyama Y, Yamatodani A, Kimura M, Tohya K, Morimoto M, Kitayama H, Kanakura Y, Kitamura Y: Transforming and differentiation-inducing potential of constitutively activated c-kit mutant genes in the IC-2 murine interleukin-3-dependent mast cell line. Am J Pathol 148:189, 1996
245. Piao X, Bernstein A: A point mutation in the catalytic domain of c-kit induces growth factor independence, tumorigenicity, and differentiation of mast cells. Blood 87:3117, 1996
246. Kitayama H, Tsujimura T, Matsumura I, Oritani K, Ikeda H, Ishikawa J, Okabe M, Suzuki M, Yamamura K-i, Matsuzawa Y, Kitamura Y, Kanakura Y: Neoplastic transformation of normal hematopoietic cells by constitutively activating mutations of c-kit receptor tyrosine kinase. Blood 88:995, 1996
247. Nagata H, Worobec AS, Oh CK, Chowdhury BA, Tannenbaum S, Suzuki Y, Metcalfe DD: Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci USA 92:10560, 1995
248. Longley BJ, Tyrrell L, Lu S-Z, Ma Y-S, Langley K, Ding T-g, Duffy T, Jacobs P, Tang LH, Modlin I: Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: Establishment of clonality in a human mast cell neoplasm. Nat Genet 12:312, 1996
249. Piao X, Paulson R, van der Geer P, Pawson T, Bernstein A: Oncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1. Proc Natl Acad Sci USA 93:14665, 1996
250. Kitayama H, Kanakura Y, Furitsu T, Tsujimura T, Oritani K, Ikeda H, Sugahara H, Mitsui H, Kanayama Y, Kitamura Y, Matsuzawa Y: Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines. Blood 85:790, 1995
251. Tsujimura T, Morimoto M, Hashimoto K, Moriyama Y, Kitayama H, Matsuzawa Y, Kitamura Y, Kanakura Y: Constitutive activation of c-kit in FMA3 murine mastocytoma cells caused by deletion of seven amino acids at the juxtamembrane domain. Blood 87:273, 1996
252. Giebel LB, Spritz RA: Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism. Proc Natl Acad Sci USA 88:8696, 1991
253. Fleischman RA: Human piebald trait resulting from a dominant negative mutant allele of the c-kit membrane receptor gene. J Clin Invest 89:1713, 1992
254. Spritz RA, Giebel LB, Holmes SA: Dominant negative and loss of function mutations of the c-kit (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism. Am J Hum Genet 50:261, 1992
255. Spritz RA, Holmes SA, Ramesar R, Greenberg J, Curtis D, Beighton P: Mutations of the KIT (mast/stem cell growth factor receptor) proto-oncogene account for a continuous range of phenotypes in human piebaldism. Am J Hum Genet 51:1058, 1992
256. Okada S, Nakauchi H, Nagayoshi K, Nishikawa S, Nishikawa S, Miura Y, Suda T: Enrichment and characterization of murine hematopoietic stem cells that express c-kit molecule. Blood 78:1706, 1991
257. + human marrow cells that express low levels of Kit protein are enriched for long-term marrow-engrafting cells. Blood 87:4136, 1996
258. Ikuta K, Weissman IL: Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. Proc Natl Acad Sci USA 89:1502, 1992
259. Li CL, Johnson GR: Murine hematopoietic stem and progenitor cells: I. Enrichment and biologic characterization. Blood 85:1472, 1995
260. Jones RJ, Collector MI, Barber JP, Vala MS, Fackler MJ, May WS, Griffin CA, Hawkins AL, Zehnbauer BA, Hilton J, Colvin OM, Sharkis SJ: Characterization of mouse lymphohematopoietic stem cells lacking spleen colony-forming activity. Blood 88:487, 1996
261. Osawa M, Hanada K, Hamada H, Nakauchi H: Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 273:242, 1996
262. - hemopoietic stem cells. J Immunol 156:3207, 1996
263. Ashman LK, Cambareri AC, To LB, Levinsky RJ, Juttner CA: Expression of the YB5.B8 antigen (c-kit proto-oncogene product) in normal human bone marrow. Blood 78:30, 1991
264. Broudy VC, Lin N, Zsebo KM, Birkett NC, Smith KA, Bernstein ID, Papayannopoulou T: Isolation and characterization of a monoclonal antibody that recognizes the human c-kit receptor. Blood 79:338, 1992
265. Papayannopoulou T, Brice M, Broudy VC, Zsebo KM: Isolation of c-kit receptor-expressing cells from bone marrow, peripheral blood, and fetal liver: Functional properties and composite antigenic profile. Blood 78:1403, 1991
266. Briddell RA, Broudy VC, Bruno E, Brandt JE, Srour EF, Hoffman R: Further phenotypic characterization and isolation of human hematopoietic progenitor cells using a monoclonal antibody to the c-kit receptor. Blood 79:3159, 1992
267. De Jong MO, Wagemaker G, Wognum AW: Separation of myeloid and erythroid progenitors based on expression of CD34 and c-kit. Blood 86:4076, 1995
268. Olweus J, Terstappen LWMM, Thompson PA, Lund-Johansen F: Expression and function of receptors for stem cell factor and erythropoietin during lineage commitment of human hematopoietic progenitor cells. Blood 88:1594, 1996
269. Yee NS, Langen H, Besmer P: Mechanism of kit ligand, phorbol ester, and calcium-induced down-regulation of c-kit receptors in mast cells. J Biol Chem 268:14189, 1993
270. Katayama N, Shih J-P, Nishikawa S, Kina T, Clark SC, Ogawa M: Stage-specific expression of c-kit protein by murine hematopoietic progenitors. Blood 82:2353, 1993
271. Wang C, Curtis JE, Geissler EN, McCulloch EA, Minden MD: The expression of the proto-oncogene c-kit in the blast cells of acute myeloblastic leukemia. Leukemia 3:699, 1989
272. Ikeda H, Kanakura Y, Tamaki T, Kuriu A, Kitayama H, Ishikawa J, Kanayama Y, Yonezawa T, Tarui S, Griffin JD: Expression and functional role of the proto-oncogene c-kit in acute myeloblastic leukemia cells. Blood 78:2962, 1991
273. Broudy VC, Smith FO, Lin N, Zsebo KM, Egrie J, Bernstein ID: Blasts from patients with acute myelogenous leukemia express functional receptors for stem cell factor. Blood 80:60, 1992
274. c-kit) is a human bone marrow surface antigen of hemopoietic precursor cells which is expressed on a subset of acute non-lymphoblastic leukemic cells. Leukemia 5:854, 1991
275. + anaplastic large cell lymphomas. Blood 83:785, 1994
276. Tomeczkowski J, Beilken A, Frick D, Wieland B, König A, Falk MH, Reiter A, Weite K, Sykora K-W: Absence of c-kit receptor and absent proliferative response to stem cell factor in childhood Burkitt's lymphoma cells. Blood 86:1469, 1995
277. Hu Z-B, Ma W, Uphoff CC, Quentmeier H, Drexler HG: c-kit expression in human megakaryoblastic leukemia cell lines. Blood 83:2133, 1994
278. Abkowitz JL, Broudy VC, Bennett LG, Zsebo KM, Martin FH: Absence of abnormalities of c-kit or its ligand in two patients with Diamond-Blackfan anemia. Blood 79:25, 1992
279. Turner AM, Zsebo KM, Martin F, Jacobsen FW, Bennett LG, Broudy VC: Nonhematopoietic tumor cell lines express stem cell factor and display c-kit receptors. Blood 80:374, 1992
280. Cohen PS, Chan JP, Lipkunskaya M, Biedler JL, Seeger RC, The Children's Cancer Group: Expression of stem cell factor and c-kit in human neuroblastoma. Blood 84:3465, 1994
281. Sekido Y, Obata Y, Ueda R, Hida T, Suyama M, Shimokata K, Ariyoshi Y, Takahashi T: Preferential expression of c-kit protooncogene transcripts in small cell lung cancer. Cancer Res 51:2416, 1991
282. Natali PG, Nicotra MR, Sures I, Santoro E, Bigotti A, Ullrich A: Expression of c-kit receptor in normal and transformed human nonlymphoid tissues. Cancer Res 52:6139, 1992
283. Strohmeyer T, Peter S, Hartmann M, Munemitsu S, Ackermann R, Ullrich A, Slamon DJ: Expression of the hst-1 and c-kit protooncogenes in human testicular germ cell tumors. Cancer Res 51:1811, 1991
284. Miyazawa K, Toyama K, Gotoh A, Hendrie PC, Mantel C, Broxmeyer HE: Ligand-dependent polyubiquitination of c-kit gene product: A possible mechanism of receptor down modulation in M07e cells. Blood 83:137, 1994
285. Yee NS, Hsiau C-WM, Serve H, Vosseller K, Besmer P: Mechanism of down-regulation of c-kit receptor. J Biol Chem 269:31991, 1994
286. Sorkin A, Waters CM: Endocytosis of growth factor receptors. Bioessays 15:375, 1993
287. Dubois CM, Ruscetti FW, Stankova J, Keller JR: Transforming growth factor-β regulates c-kit message stability and cell-surface protein expression in hematopoietic progenitors. Blood 83:3138, 1994
288. + cells via p55 TNFα receptors. Blood 84:2506, 1994
289. Sillaber C, Strobl H, Bevec D, Ashman LK, Butterfield JH, Lechner K, Maurer D, Bettelheim P, Valent P: IL-4 regulates c-kit proto-oncogene product expression in human mast and myeloid progenitor cells. J Immunol 147:4224, 1991
290. Rusten LS, Smeland EB, Jacobsen FW, Lien E, Lesslauer W, Loetscher H, Dubois CM, Jacobsen SEW: Tumor necrosis factor-α inhibits stem cell factor-induced proliferation of human bone marrow progenitor cells in vitro. J Clin Invest 94:165, 1994
291. Brizzi MF, Blechman JM, Cavalloni G, Givol D, Yarden Y, Pegoraro L: Protein kinase C-dependent release of a functional whole extracellular domain of the mast cell growth factor (MGF) receptor by MGF-depdendent human myeloid cells. Oncogene 9:1583, 1994
292. Rose-John S, Heinrich PC: Soluble receptors for cytokines and growth factors: Generation and biological function. Biochem J 300:281, 1994
293. Heaney ML, Golde DW: Soluble cytokine receptors. Blood 87:847, 1996
294. Peters M, Jacobs S, Ehlers M, Vollmer P, Müllberg J, Wolf E, Brem G, zum Büschenfelde K-HM, Rose-John S: The function of the soluble interleukin 6 (IL-6) receptor in vivo: Sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6. J Exp Med 183:1399, 1996
295. Kishimoto T, Akira S, Narazaki M, Taga T: Interleukin-6 family of cytokines and gp130. Blood 86:1243, 1995
296. Ku H, Hirayama F, Kato T, Miyazaki H, Aritomi M, Ota Y, D'Andrea AD, Lyman SD, Ogawa M: Soluble thrombopoietin receptor (Mpl) and granulocyte colony-stimulating factor receptor directly stimulate proliferation of primitive hematopoietic progenitors of mice in synergy with steel factor or the ligand for flt3/flk2. Blood 88:4124, 1996
297. Wells A, Welsh JB, Lazar CS, Wiley HS, Gill GN, Rosenld MG: Ligand-induced transformation by a noninternalizing epidermal growth factor receptor. Science 247:962, 1990
298. Wypyeh J, Bennett LG, Schwartz MG, Clogston CL, Lu HS, Broudy VC, Bartley TD, Parker VP, Langley KE: Soluble Kit receptor in human serum. Blood 85:66, 1995
299. c region of human IgG expressed in a baculovirus system. Biochem Biophys Res Commun 197:1094, 1993
300. Grichnik JM, Crawford J, Jimenez F, Kurtzberg J, Buchanan M, Blackwell S, Clark RE, Hitchcock MG: Human recombinant stem-cell factor induces melanocytic hyperplasia in susceptible patients. J Am Acad Dermatol 33:577, 1995
301. Moskowitz CH, Stiff P, Gordon MS, McNiece I, Ho AD, Costa JJ, Broun ER, Bayer RA, Wyres M, Hill J, Jelaca-Maxwell K, Nichols CR, Brown SL, Nimer SD, Gabrilove J: Recombinant methionyl human stem cell factor and filgrastin for peripheral blood progenitor cell mobilization and transplantation in non-Hodgkin's lymphoma patients - Results of a phase I/II trial. Blood 89:3136, 1997
302. Tricot G, Jagannath S, Desikan KR, Siegel D, Munshi N, Olson E, Wyres M, Parker W, Barlogie B: Superior mobilization of peripheral blood progenitor ceffs (PBPC) with r-metHuSCF (SCF) and r-metHuG-CSF (Filgrastim) in heavily pretreated multiple myeloma (MM) patients. Blood 88:388a, 1996 (abstr, suppl 1)
303. Nocka KH, Levine BA, Ko J-L, Burch PM, Landgraf BE, Segal R, Lobell R: Increased growth promoting but not mast cell degranulation potential of a covalent dimer of c-Kit ligand. Blood (in press)
304. Nocka KH, Burch P, Levine BA, Undem B, Segal R, Nair N, Alessi MK, Landgraf BE, Lobell R: Human c-kit ligand analogue, SAF-9, with increased growth factor but not mast cell stimulating activity. Blood 88:548a, 1996 (abstr, suppl 1)
305. Luskey BD, Rosenblatt M, Zsebo K, Williams DA: Stem cell factor, interleukin-3, and interleukin-6 promote retroviral-mediated gene transfer into murine hematopoietic stem cells. Blood 80:396, 1992
306. Williams DA: Ex vivo expansion of hematopoietic stem and progenitor cells - Robbing Peter to pay Paul? Blood 81:3169, 1993
307. Emerson SG: Ex vivo expansion of hematopoietic precursors, progenitors, and stem cells: The next generation of cellular therapeutics. Blood 87:3082, 1996
308. Ratajczak MZ, Pletcher C, Marliez W, Wasik M, Machalinski B, Ratajczak J, Moore J, Gewirtz AM: A rapid method for isolating human hematopoietic stem cells (HHSC). Blood 88:109a, 1996 (abstr, suppl 1)
309. Kasahara N, Dozy AM, Kan YW: Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science 266:1373, 1994
310. Schwarzenberger P, Spence SE, Gooya JM, Michiel D, Curiel DT, Ruscetti FW, Keller JR: Targeted gene transfer to human hematopoietic progenitor cell lines through the c-kit receptor. Blood 87:472, 1996
311. Hsu Y-R, Wu G-M, Mendiaz EA, Syed R, Wypych J, Toso R, Mann MB, Boone TC, Narhi LO, Lu HS, Langley KE: The majority of stem cell factor exists as monomer under physiological conditions. J Biol Chem 272:6406, 1997
312. Lemmon MA, Pinchasi D, Zhou M, Lax I, Schlessinger J: Kit receptor dimerization is driven by bivalent binding of stem cell factor. J Biol Chem 272:6311, 1997